Brexit and Pharmaceuticals’ Regulations: Optimising the UK’s Post-Brexit Influence in Global Standards-Setting (2017) healthyBrexit Briefing Paper 1

Mark Flear

Brexit and Pharmaceuticals’ Regulations: Optimising the UK’s Post-Brexit Influence in Global Standards-Setting (2017) healthyBrexit Briefing Paper 1

School of Law

Research output: Working paper

Original language	English
Publication status	Published - 01 May 2017

Publication series

Name	healthyBrexit Briefing Paper

Cite this

@techreport{0625a6d14cc04032a73bc192df1c24bd,

title = "Brexit and Pharmaceuticals{\textquoteright} Regulations: Optimising the UK{\textquoteright}s Post-Brexit Influence in Global Standards-Setting (2017) healthyBrexit Briefing Paper 1",

author = "Mark Flear",

year = "2017",

month = may,

day = "1",

language = "English",

series = "healthyBrexit Briefing Paper",

type = "WorkingPaper",

}

TY - UNPB

T1 - Brexit and Pharmaceuticals’ Regulations: Optimising the UK’s Post-Brexit Influence in Global Standards-Setting (2017) healthyBrexit Briefing Paper 1

AU - Flear, Mark

PY - 2017/5/1

Y1 - 2017/5/1

M3 - Working paper

T3 - healthyBrexit Briefing Paper

BT - Brexit and Pharmaceuticals’ Regulations: Optimising the UK’s Post-Brexit Influence in Global Standards-Setting (2017) healthyBrexit Briefing Paper 1

ER -